10 drugs that are likely targets for fall Medicare price negotiations

It's still unclear which drugs Medicare will select, but several companies have revealed in court filings that four of their medications are targets.

Related Keywords

,Gsk Plc ,Astellas Pharma Inc ,Pfizer Inc ,Astrazeneca Plc ,Amgen Inc ,Abbvie Inc ,Johnson Amp ,Bristol Myers Squibb Co ,Merck Amp Co Inc ,Business ,Health Care Industry ,Politics ,Us Economy ,Biotech And Pharmaceuticals ,Biotechnology ,Breaking News Business ,Business News ,